Magda Michna - 08 May 2023 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Chief Clinical, Regulatory,
Signature
/s/ Samuel Gesten as attorney-in-fact for Magda Michna
Issuer symbol
STAA
Transactions as of
08 May 2023
Net transactions value
$0
Form type
4
Filing time
09 May 2023, 17:26:16 UTC
Previous filing
29 Mar 2023
Next filing
14 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $0 +14,047 $0.000000 14,047 08 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 +25,955 $0.000000 25,955 08 May 2023 Common Stock 25,955 $67.63 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of 14,047 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the shares (4682) on 5/08/24, 1/3 of the shares (4682) on 5/08/25, and 1/3 of the shares (4683) on 5/08/26.
F2 The options granted become exercisable as follows: 1/3 on 5/08/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 5/08/2026.

Remarks:

This Form 4 reflects the equity grant to Dr. Michna related to her appointment as Chief Clinical, Regulatory and Medical Affairs Officer.